Symptomatic thrombosis in Turkish neonates

Journal of Pediatric Hematology/Oncology

Volumn 26, Issue 7, 2004, Pages 417-420

  Gurgey, Aytemiz ^a   Tekinalp, Gulsevin ^a   Cinar, Asli ^a   Cakmak, Fatmanur ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b I Neurosurgery Clinic   (Turkey)

Author keywords

Factor V G1691A; Neonate; Prothrombin G20210A; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5; PROTHROMBIN;

ARTICLE; CLINICAL ARTICLE; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOSITY; HUMAN; IDIOPATHIC DISEASE; MALE; NEWBORN; PRIORITY JOURNAL; SYMPTOMATOLOGY; THROMBOEMBOLISM; THROMBOPHILIA; THROMBOSIS; TURKEY (REPUBLIC);

FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; MALE; MUTATION; PROTHROMBIN; RISK FACTORS; THROMBOSIS; TURKEY;

EID: 3543145560     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200407000-00003     Document Type: Article

References (18)

1. Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics. 1995;96:939-943.
2. Nowak-Gottl U, von Kries R, Gobel U. Neonatal symptomatic thromboembolism in Germany: two-year survey. Arch Dis Child Fetal Neonatal Ed. 1997;76:F163-F167.
3. Andrew M. Developmental haemostasis relevance to thromboembolic complications in pediatric patients. Thromb Haemost. 1995;74:415-425.
4. David M, Andrew M. Venous thromboembolic complications in children. J Pediatr. 1993;123:337-346.
5. Nowak-Gottl U, Kosch A, Schlagel N. Neonatal thromboembolism. Semin Thromb Hemost. 2003;29:227-234.
6. Manco-Johnson M, Nuss R. Neonatal Thrombotic disorders. Neoreviews. 2000;10:e201-e204.
7. Dogan Y, Aygun D, Yilmaz Y, et al. Severe protein S deficiency associated with heterozygous factor V Leiden mutation in a child with purpura fulminans. Pediatr Hematol Oncol. 2003;20:1-5.
8. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67.
9. Poort SR, Rosendaal FR, Reltsma PH, et al. A common genetic variation in the 3′-untraslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703.
10. Froost P, Blom HJ, Milos R, et al. Candidate genetic factors for vascular disease: a common mutation in methylenetetrahyrofolate reductase. Nat Genet. 1995;10:111-113.
11. Gurgey A, Haznedaroglu IC, Egesel T, et al. Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis. Am J Hematol. 2001;67:107-111.
12. Gurgey A, Mesci L, Renda Y, et al. Factor V Q 506 mutation in children with thrombosis. Am J Hemotol. 1996;53:37-39.
13. Schobess R, Junker R, Auberger K, et al. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis-evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation. Eur J Pediatr. 1999;158(Suppl 3):S105-S108
14. Gurgey A, Aslan D. Outcome of non-catheter-related thrombosis in children: influences of underlying or coexisting factors. J Pediatr Hematol Oncol. 2001;23:159-164.
15. Nowak-Göttl U, Koch HG, Aschka I, et al. Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Haematol. 1996;92:992-998.
16. Hagstrom JN, Walter J, Bluebond-Langner R. Prevalence of factor V Leiden children and neonates with thromboembolic disease. J Pediatr. 1998;133:777-781.
17. Gunther G, Junker R, Strater R, et al. Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombotic risk factors. Stroke. 2000;31:2437-2441.
18. Heller C, Becker S, Scharrer I, et al. Prothrombotic risk factors in childhood stroke and venous thrombosis. Eur J Pediatr. 1999;158(Suppl 3):S117-S121.